Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium+ Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  12/10/2015
1245.25.10182 Boehringer Ingelheim Investigational Site
mi
from
Morgantown, WV
Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium+ Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 12/10/2015
1245.25.10182 Boehringer Ingelheim Investigational Site
mi
from
Morgantown, WV
Click here to add this to my saved trials
Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium+ Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  12/10/2015
1237.26.61004 Boehringer Ingelheim Investigational Site
mi
from
Concord,
Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)
A Randomised, Double-blind, Placebo- and Active-controlled Parallel Group Study to Assess the Efficacy of 12 Weeks of Once Daily Treatment of Two Doses of Orally Inhaled Tiotropium+ Olodaterol Fixed Dose Combination (Delivered by the Respimat Inhaler) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 12/10/2015
1237.26.61004 Boehringer Ingelheim Investigational Site
mi
from
Concord,
Click here to add this to my saved trials
Effects of CPAP Therapy on PTSD Symptoms
Effects of Continuous Positive Airway Pressure Therapy for Obstructive Sleep Apnea on PTSD Symptoms
Status: Enrolling
Updated:  12/10/2015
VA San Diego Healthcare System
mi
from
San Diego, CA
Effects of CPAP Therapy on PTSD Symptoms
Effects of Continuous Positive Airway Pressure Therapy for Obstructive Sleep Apnea on PTSD Symptoms
Status: Enrolling
Updated: 12/10/2015
VA San Diego Healthcare System
mi
from
San Diego, CA
Click here to add this to my saved trials
The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA).
A Pilot Study to Evaluate if Caffeine Helps Children With Obstructive Sleep Apnea Recover Faster From Anesthesia, and With Less Complications After General Anesthesia for Tonsillectomy and Adenoidectomy.
Status: Enrolling
Updated:  12/11/2015
University of Texas Health Science Center at Houston; Children's Memorial Hermann Hospital
mi
from
Houston, TX
The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA).
A Pilot Study to Evaluate if Caffeine Helps Children With Obstructive Sleep Apnea Recover Faster From Anesthesia, and With Less Complications After General Anesthesia for Tonsillectomy and Adenoidectomy.
Status: Enrolling
Updated: 12/11/2015
University of Texas Health Science Center at Houston; Children's Memorial Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of the Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, RSV MEDI ΔM2-2 Lot RSV#002A, Delivered as Nose Drops to Adults 18 to 49 Years of Age, RSV-Seropositive Children 12 to 59 Months of Age, and RSV-Seronegative Infants and Children 6 to 24 Months of Age
Status: Enrolling
Updated:  12/14/2015
John Hopkins Center for Immunization Research
mi
from
Baltimore, MD
Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children
A Phase I Study of the Safety and Immunogenicity of the Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, RSV MEDI ΔM2-2 Lot RSV#002A, Delivered as Nose Drops to Adults 18 to 49 Years of Age, RSV-Seropositive Children 12 to 59 Months of Age, and RSV-Seronegative Infants and Children 6 to 24 Months of Age
Status: Enrolling
Updated: 12/14/2015
John Hopkins Center for Immunization Research
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of Sleep Disordered Breathing Following Ambulatory Surgery
Postoperative Home Sleep Test Changes in Ambulatory Surgical Patients With and Without Obstructive Sleep Apnea: A Prospective Clinical Trial
Status: Enrolling
Updated:  12/14/2015
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Evaluation of Sleep Disordered Breathing Following Ambulatory Surgery
Postoperative Home Sleep Test Changes in Ambulatory Surgical Patients With and Without Obstructive Sleep Apnea: A Prospective Clinical Trial
Status: Enrolling
Updated: 12/14/2015
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Sexual Dysfunction And Hypotestosteronemia In Patients With Obstructive Sleep Apnea Syndrome
Sexual Dysfunction And Hypotestosteronemia In Patients With Obstructive Sleep Apnea Syndrome And Its Effects With CPAP Therapy
Status: Enrolling
Updated:  12/15/2015
Lahey Clinic
mi
from
Burlington, MA
Sexual Dysfunction And Hypotestosteronemia In Patients With Obstructive Sleep Apnea Syndrome
Sexual Dysfunction And Hypotestosteronemia In Patients With Obstructive Sleep Apnea Syndrome And Its Effects With CPAP Therapy
Status: Enrolling
Updated: 12/15/2015
Lahey Clinic
mi
from
Burlington, MA
Click here to add this to my saved trials
Sexual Dysfunction And Hypotestosteronemia In Patients With Obstructive Sleep Apnea Syndrome
Sexual Dysfunction And Hypotestosteronemia In Patients With Obstructive Sleep Apnea Syndrome And Its Effects With CPAP Therapy
Status: Enrolling
Updated:  12/15/2015
Lahey Clinic Northshore
mi
from
Peabody, MA
Sexual Dysfunction And Hypotestosteronemia In Patients With Obstructive Sleep Apnea Syndrome
Sexual Dysfunction And Hypotestosteronemia In Patients With Obstructive Sleep Apnea Syndrome And Its Effects With CPAP Therapy
Status: Enrolling
Updated: 12/15/2015
Lahey Clinic Northshore
mi
from
Peabody, MA
Click here to add this to my saved trials
Effectiveness of Extended Treatment for Drug Dependence (ETDD) in the City Study
Effectiveness of Extended Treatment for Drug Dependence - City Supplement
Status: Enrolling
Updated:  12/21/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Effectiveness of Extended Treatment for Drug Dependence (ETDD) in the City Study
Effectiveness of Extended Treatment for Drug Dependence - City Supplement
Status: Enrolling
Updated: 12/21/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effectiveness of Enhanced Treatments for Drug Dependence
Effectiveness of an Enhanced Adaptive Continuing Care Model for Cocaine Dependence
Status: Enrolling
Updated:  12/21/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Effectiveness of Enhanced Treatments for Drug Dependence
Effectiveness of an Enhanced Adaptive Continuing Care Model for Cocaine Dependence
Status: Enrolling
Updated: 12/21/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
IOP Fluctuations in Patients With Sleep Apnea With or Without Primary Open Angle Glaucoma Using Positive Airway Pressure
A Prospective, Explorative, Open Label Study to Assess the 24-hour Intraocular Pressure Fluctuation Profile Recorded With SENSIMED Triggerfish® in Patients With Moderate to Severe Obstructive Sleep Apnea Syndrome Using Continuous Positive Airway Pressure With or Without Primary Open Angle Glaucoma
Status: Enrolling
Updated:  12/21/2015
The New York Eye and Ear Infirmary
mi
from
New-York, NY
IOP Fluctuations in Patients With Sleep Apnea With or Without Primary Open Angle Glaucoma Using Positive Airway Pressure
A Prospective, Explorative, Open Label Study to Assess the 24-hour Intraocular Pressure Fluctuation Profile Recorded With SENSIMED Triggerfish® in Patients With Moderate to Severe Obstructive Sleep Apnea Syndrome Using Continuous Positive Airway Pressure With or Without Primary Open Angle Glaucoma
Status: Enrolling
Updated: 12/21/2015
The New York Eye and Ear Infirmary
mi
from
New-York, NY
Click here to add this to my saved trials
Behavioral Interventions for Control of TB
Behavioral Interventions for Control of Tuberculosis
Status: Enrolling
Updated:  12/21/2015
Columbia University
mi
from
New York, NY
Behavioral Interventions for Control of TB
Behavioral Interventions for Control of Tuberculosis
Status: Enrolling
Updated: 12/21/2015
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS)
Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation
Status: Enrolling
Updated:  12/22/2015
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS)
Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation
Status: Enrolling
Updated: 12/22/2015
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS)
Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation
Status: Enrolling
Updated:  12/22/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS)
Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation
Status: Enrolling
Updated: 12/22/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Childhood Asthma Program in NYC Health Department Clinics
Improving Care for Minority Children With Asthma: Professional Education in Public Health Clinics
Status: Enrolling
Updated:  12/22/2015
Columbia University
mi
from
New York, NY
Childhood Asthma Program in NYC Health Department Clinics
Improving Care for Minority Children With Asthma: Professional Education in Public Health Clinics
Status: Enrolling
Updated: 12/22/2015
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
Status: Enrolling
Updated:  12/23/2015
Valley Children's Healthcare
mi
from
Madera, CA
Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
Status: Enrolling
Updated: 12/23/2015
Valley Children's Healthcare
mi
from
Madera, CA
Click here to add this to my saved trials
Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
Status: Enrolling
Updated:  12/23/2015
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
Status: Enrolling
Updated: 12/23/2015
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
Status: Enrolling
Updated:  12/23/2015
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
Status: Enrolling
Updated: 12/23/2015
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Exhaled Nitric Oxide Levels in Infants and Young Children Infected With RSV or Other Viral Infections
A Prospective Study Measuring Exhaled Nitric Oxide Levels in Infants and Young Children Admitted to the Hospital for Respiratory Syncytial Virus (RSV) or Other Viral Lower Respiratory Tract Infections
Status: Enrolling
Updated:  12/23/2015
Winthrop University Hospital
mi
from
Mineola, NY
Exhaled Nitric Oxide Levels in Infants and Young Children Infected With RSV or Other Viral Infections
A Prospective Study Measuring Exhaled Nitric Oxide Levels in Infants and Young Children Admitted to the Hospital for Respiratory Syncytial Virus (RSV) or Other Viral Lower Respiratory Tract Infections
Status: Enrolling
Updated: 12/23/2015
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Randomized Trial of Physical Activity Self-Management Intervention for Patients With COPD
Randomized Trial of Physical Activity Self-Management Intervention for Patients With COPD
Status: Enrolling
Updated:  12/24/2015
University of Texas Health Science Center at Tyler
mi
from
Tyler, TX
Randomized Trial of Physical Activity Self-Management Intervention for Patients With COPD
Randomized Trial of Physical Activity Self-Management Intervention for Patients With COPD
Status: Enrolling
Updated: 12/24/2015
University of Texas Health Science Center at Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
Does Cricoid Pressure Reduce the Risk of Aspiration?
Does Cricoid Pressure Reduce the Risk of Aspiration?
Status: Enrolling
Updated:  12/30/2015
Mayo Clinic Rochester
mi
from
Rochester, MN
Does Cricoid Pressure Reduce the Risk of Aspiration?
Does Cricoid Pressure Reduce the Risk of Aspiration?
Status: Enrolling
Updated: 12/30/2015
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Does Cricoid Pressure Reduce the Risk of Aspiration?
Does Cricoid Pressure Reduce the Risk of Aspiration?
Status: Enrolling
Updated:  12/30/2015
Mayo Clinic - Saint Mary's Campus
mi
from
Rochester, MN
Does Cricoid Pressure Reduce the Risk of Aspiration?
Does Cricoid Pressure Reduce the Risk of Aspiration?
Status: Enrolling
Updated: 12/30/2015
Mayo Clinic - Saint Mary's Campus
mi
from
Rochester, MN
Click here to add this to my saved trials
Adaptive Treatment for Cocaine Dependence
Adaptive Treatment for Cocaine Dependence
Status: Enrolling
Updated:  1/4/2016
Presbyterian Med Ctr
mi
from
Philadelphia, PA
Adaptive Treatment for Cocaine Dependence
Adaptive Treatment for Cocaine Dependence
Status: Enrolling
Updated: 1/4/2016
Presbyterian Med Ctr
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Adaptive Treatment for Cocaine Dependence
Adaptive Treatment for Cocaine Dependence
Status: Enrolling
Updated:  1/4/2016
NorthEast Treatment Center
mi
from
Philadelphia, PA
Adaptive Treatment for Cocaine Dependence
Adaptive Treatment for Cocaine Dependence
Status: Enrolling
Updated: 1/4/2016
NorthEast Treatment Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Adaptive Treatment for Cocaine Dependence
Adaptive Treatment for Cocaine Dependence
Status: Enrolling
Updated:  1/4/2016
VAMC
mi
from
Philadelphia, PA
Adaptive Treatment for Cocaine Dependence
Adaptive Treatment for Cocaine Dependence
Status: Enrolling
Updated: 1/4/2016
VAMC
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Apoptotic Cell (AC) Uptake by Human Alveolar Macrophages (AM)
Apoptotic Cell Ingestion by Normal Human Alveolar Macrophages
Status: Enrolling
Updated:  1/4/2016
VA Ann Arbor Healthcare System, Ann Arbor, MI
mi
from
Ann Arbor, MI
Apoptotic Cell (AC) Uptake by Human Alveolar Macrophages (AM)
Apoptotic Cell Ingestion by Normal Human Alveolar Macrophages
Status: Enrolling
Updated: 1/4/2016
VA Ann Arbor Healthcare System, Ann Arbor, MI
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
A Multicenter, Open-Label, Phase II Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations
Status: Enrolling
Updated:  1/4/2016
Geisinger Medical Center
mi
from
Danville, PA
A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
A Multicenter, Open-Label, Phase II Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations
Status: Enrolling
Updated: 1/4/2016
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
A Multicenter, Open-Label, Phase II Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations
Status: Enrolling
Updated:  1/4/2016
Temple University Medical Center
mi
from
Philladelphia, PA
A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
A Multicenter, Open-Label, Phase II Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations
Status: Enrolling
Updated: 1/4/2016
Temple University Medical Center
mi
from
Philladelphia, PA
Click here to add this to my saved trials
A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
A Multicenter, Open-Label, Phase II Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations
Status: Enrolling
Updated:  1/4/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
A Multicenter, Open-Label, Phase II Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations
Status: Enrolling
Updated: 1/4/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
A Multicenter, Open-Label, Phase II Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations
Status: Enrolling
Updated:  1/4/2016
Inova Fairfax Heart and Vascular Institute
mi
from
Falls Church, VA
A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
A Multicenter, Open-Label, Phase II Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations
Status: Enrolling
Updated: 1/4/2016
Inova Fairfax Heart and Vascular Institute
mi
from
Falls Church, VA
Click here to add this to my saved trials
A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
A Multicenter, Open-Label, Phase II Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations
Status: Enrolling
Updated:  1/4/2016
University of Texas Medical Branch at Galveston
mi
from
Galveston, TX
A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations
A Multicenter, Open-Label, Phase II Study of Combined Plasma Exchange (PEX), Rituximab, and Corticosteroids in Patients With Acute Idiopathic Pulmonary Fibrosis Exacerbations
Status: Enrolling
Updated: 1/4/2016
University of Texas Medical Branch at Galveston
mi
from
Galveston, TX
Click here to add this to my saved trials
PK Study of N91115 in Cystic Fibrosis Patients
A Phase 1, Open-Label Study Evaluating the Pharmacokinetics of N91115 in Cystic Fibrosis Patients
Status: Enrolling
Updated:  1/4/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
PK Study of N91115 in Cystic Fibrosis Patients
A Phase 1, Open-Label Study Evaluating the Pharmacokinetics of N91115 in Cystic Fibrosis Patients
Status: Enrolling
Updated: 1/4/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
PK Study of N91115 in Cystic Fibrosis Patients
A Phase 1, Open-Label Study Evaluating the Pharmacokinetics of N91115 in Cystic Fibrosis Patients
Status: Enrolling
Updated:  1/4/2016
Children's CO
mi
from
Aurora, CO
PK Study of N91115 in Cystic Fibrosis Patients
A Phase 1, Open-Label Study Evaluating the Pharmacokinetics of N91115 in Cystic Fibrosis Patients
Status: Enrolling
Updated: 1/4/2016
Children's CO
mi
from
Aurora, CO
Click here to add this to my saved trials
PK Study of N91115 in Cystic Fibrosis Patients
A Phase 1, Open-Label Study Evaluating the Pharmacokinetics of N91115 in Cystic Fibrosis Patients
Status: Enrolling
Updated:  1/4/2016
National Jewish Health
mi
from
Denver, CO
PK Study of N91115 in Cystic Fibrosis Patients
A Phase 1, Open-Label Study Evaluating the Pharmacokinetics of N91115 in Cystic Fibrosis Patients
Status: Enrolling
Updated: 1/4/2016
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
Children's CO
mi
from
Aurora, CO
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
Children's CO
mi
from
Aurora, CO
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
National Jewish Health
mi
from
Denver, CO
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
Indiana University
mi
from
Indianapolis, IN
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
University of Iowa Children's Hospital
mi
from
Iowa City, IA
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
University of Iowa Children's Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
Boston Children's Hospital
mi
from
Boston, MA
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
Univ of Minnesota
mi
from
Minneapolis, MN
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
Washington University
mi
from
St. Louis, MO
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
Columbia University
mi
from
New York, NY
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
New York Presbyterian Hospital - Columbia University Medical Center
mi
from
New York, NY
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
New York Presbyterian Hospital - Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
Rainbow Babies and Children's Hospital - Case Medical Center
mi
from
Cleveland, OH
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
Rainbow Babies and Children's Hospital - Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
Seattle Children's Hospital
mi
from
Seattle, WA
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated:  1/4/2016
Stanford University
mi
from
Palo Alto, CA
Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR Mutation
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Study of N91115 to Evaluate Safety and Pharmacokinetics in Patients With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation
Status: Enrolling
Updated: 1/4/2016
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials